© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 02, 2022
Oteseconazole (Vivjoa) reduces the incidence of recurrent vulvovaginal candidiasis.
October 25, 2021
"The spread of misinformation and mistrust in doctors and science is contributing to staggeringly low vaccination rates among pregnant people," said the American Colleges of Obstetricians and Gynecologists.
May 27, 2021
A recent test found various brands and batches of sunscreen and after-sun care products contained benzene, a potential carcinogen.
March 23, 2021
Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose.